Objectives: Epidemiological studies have demonstrated that hypertensive disorders of pregnancy (HDP) are associated with postpartum cardiovascular (CV) dysfunction. Recent evidence suggests that pregnancy is associated with persistent CV changes. This study aimed to investigate whether HDP or normal pregnancy has a significant effect on postpartum CV function. Methods: A case-control study of 3 groups: women who gave birth in the past 3 years (one group had HDP; a second group had normotensive pregnancy) and a group of women who had never been pregnant. Exclusion criteria included a history of pre-pregnancy CV disorder, BMI >35kg/m 2 , multiple pregnancies or stillbirths. Blood pressure (BP) was recorded and CV function was assessed using Ultrasound Cardiac Output Monitoring (USCOM©) at a point between 6months and 3 years postpartum. CV parameters included cardiac output (CO), cardiac index (CI), stroke volume (SV), SV index (SVI), heart rate (HR), systemic vascular resistance (SVR) and SVR index (SVRI .01 for all). There was no significant difference in these CV parameters between the never pregnant women and those who had normotensive pregnancies. Conclusions: Women with a previous HDP had significantly higher BP and signs of suboptimal CV function, when compared to those who had a normotensive pregnancy or those never pregnant, and warrant postpartum CV surveillance. Normotensive pregnancy was not associated with a significant CV effect.
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The prognostic value of highly sensitive cardiac troponin I in pregnancies with pre-eclampsia: bicentric prospective study Objectives: The objective of this study was to compare the highly sensitive cardiac troponin I (hsTnI) levels between normal pregnant women and those with pre-eclampsia. Methods: A total of 60 patients were included in the study. Patients with infection, pregestational gestational diabetes history, premature membrane rupture, oligo/polyhydramnios, organic heart valve disease, hypertension, chronic renal insufficiency and those requiring positive inotropic therapy were not included in the study. The patients were assigned into two groups as the pre-eclamptic pregnant group (study group PEG, n=40) and normotensive pregnant group (control group CG, n=20). Plasma samples (ARCHITECT STAT High Sensitive Troponin-I Assay) were obtained at the time of delivery (H0), H4 and H24. Conclusions: Pre-eclampsia was associated with a rise in high sensitive troponin I levels in our study. Patients with pre-eclampsia and elevated troponin levels should have further cardiac investigations.
Results: The level of
HsTnI at H0 was significantly higher in patients with pre-eclampsia (5.2 [interquartile range IQR: 1.4
